Companies/Cure51

Cure51

Technology
HQ: Paris, France
Investors: 1

Analyzes data from long-term cancer survivors to discover new mechanisms

Investors (1)

FundStatusEntry DateStageSource
Sofinnova PartnersCurrent--Website